Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 40.11 USD -0.15% Market Closed
Market Cap: 2.4B USD

Wall Street
Price Targets

TWST Price Targets Summary
Twist Bioscience Corp

Wall Street analysts forecast TWST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TWST is 54.82 USD with a low forecast of 45.45 USD and a high forecast of 68.25 USD.

Lowest
Price Target
45.45 USD
13% Upside
Average
Price Target
54.82 USD
37% Upside
Highest
Price Target
68.25 USD
70% Upside
Twist Bioscience Corp Competitors:
Price Targets
1530
3SBio Inc
7% Downside
LGND
Ligand Pharmaceuticals Inc
35% Upside
600201
Jinyu Bio-Technology Co Ltd
16% Upside
RNA
Avidity Biosciences Inc
121% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
11% Downside
603087
Gan & Lee Pharmaceuticals
26% Upside
AMGN
Amgen Inc
17% Upside
BCRX
BioCryst Pharmaceuticals Inc
87% Upside

Revenue
Forecast

Revenue Estimate
Twist Bioscience Corp

For the last 7 years the compound annual growth rate for Twist Bioscience Corp's revenue is 62%. The projected CAGR for the next 3 years is 20%.

62%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TWST's stock price target?
Price Target
54.82 USD

According to Wall Street analysts, the average 1-year price target for TWST is 54.82 USD with a low forecast of 45.45 USD and a high forecast of 68.25 USD.

What is Twist Bioscience Corp's Revenue forecast?
Projected CAGR
20%

For the last 7 years the compound annual growth rate for Twist Bioscience Corp's revenue is 62%. The projected CAGR for the next 3 years is 20%.

Back to Top